Skip header and navigation

19 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
June 20, 2022 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602v002 RR Epidemiology & Modelling
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Infectious Disease
March 31, 2022 What is the incidence and duration of long COVID cases? EPM210601v2 RR Epidemiology & Modelling
February 4, 2022 What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines? EOC220103 RR EOC
October 29, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901v2 RR EOC
February 27, 2021 What is the final disposition of post-COVID patients who require chronic ventilation in the ICU? CC011101 RR Critical Care
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 20, 2021 What is the duration of immunity for COVID-19 in previously infected patients? INF090101v2 RR Infectious Disease
December 9, 2020 What are the predictors of mortality in hospitalized COVID-19 patients? CC120402 RR Critical Care
November 2, 2020 What is the risk of reinfection from COVID-19? [Update] EOC032401v3 RR EOC
October 15, 2020 Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients? INF092801 RR Infectious Disease
September 29, 2020 What is the evidence that runny nose or sneezing are symptoms of COVID-19? EOC092401 RR EOC
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
May 11, 2020 What percentage of COVID-19 patients have hyposmia or anosmia? EOC033102 RR EOC
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory
April 15, 2020 At what time in the disease timeline of COVID-19 do antibodies develop? LAB041402 RR Laboratory
April 11, 2020 Is the IgM or IgG immune response protective? LAB040803 RR Laboratory
April 7, 2020 What is the prevalence of sore throat as a symptom of COVID-19? EOC040201 RR EOC

19 records – page 1 of 1.